Observational studyJAMA network open2018

Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification.

Rahul Sreekumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.